Drug
Amrubicin Hydrocloride
Amrubicin Hydrocloride: highest development phase Phase 3, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Amrubicin hydrocloride NCT01207011 | Phase 3 | Lung Cancer |
Latest
No recent events.
Follow Amrubicin Hydrocloride on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.